Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
Figure 1
(a) Kaplan-Meyer curves distribution: comparison between patients with PSA ≤20 ng/mL versus patients with PSA >20 ng/mL with regard to BCR-free survival rates. PR: patients at risk; CE: cumulative number of events. (b) Kaplan-Meyer curves distribution: Comparison between patients with PSA ≤20 ng/mL versus patients with PSA >20 ng/mL with regard to OS survival rates. PR: patients at risk; CE: cumulative number of events. (c) Kaplan-Meyer curves distribution: comparison between patients with PSA ≤20 ng/mL versus patients with PSA >20 ng/mL with regard to CSS survival rates. PR: patients at risk; CE: cumulative number of events.
